Organic Pharmaceutical Excipients Market to Grow with a CAGR of 6.93% through 2028
Increased focus on sustainability and eco-friendly
practices are expected to drive the Global Organic Pharmaceutical Excipients Market
growth in the forecast period, 2024-2028.
According to TechSci Research report, “Organic
Pharmaceutical Excipients Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Organic
Pharmaceutical Excipients Market stood at USD 8.46 billion in 2022 and is
anticipated to grow with a CAGR of 6.42% in the forecast period, 2024-2028. The
global organic pharmaceutical excipients market is experiencing remarkable
growth, driven by several key factors that are reshaping the pharmaceutical
industry. Pharmaceutical excipients, traditionally regarded as inactive
ingredients, are now assuming a central role in drug formulation due to their
impact on drug stability, bioavailability, and overall performance. Among the
various types of pharmaceutical excipients, organic alternatives derived from
natural sources have been gaining significant traction, and their market is on
the rise. One of the
primary drivers behind the growth of the organic pharmaceutical excipients
market is the shifting consumer preference towards organic and natural
products. This trend is not limited to the food and beverage industry but has
extended to pharmaceuticals. Consumers are becoming increasingly
health-conscious and wary of synthetic additives in their medications. As a
result, they are seeking pharmaceutical products formulated with organic
excipients. This preference for clean-label pharmaceuticals has created a
substantial demand for organic excipients.
Regulatory bodies worldwide are becoming more
stringent when it comes to the safety and quality of pharmaceutical products.
They are encouraging pharmaceutical companies to adopt safer and more
environmentally friendly excipients in their formulations. Organic
pharmaceutical excipients, often sourced from natural materials like cellulose,
starch, and gums, are considered a sustainable and eco-friendly option. The
alignment of regulatory goals with organic excipient usage is further
propelling their market growth.
Global health concerns, including the increasing incidence
of chronic diseases and the ongoing COVID-19 pandemic, have highlighted the
need for pharmaceutical innovations. Organic excipients are playing a pivotal
role in this regard, as they offer pharmaceutical companies a versatile
platform for developing new drug formulations. The demand for effective and
safe medications to address these health issues is driving pharmaceutical
companies to explore the potential of organic excipients.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Organic
Pharmaceutical Excipients Market.”
The pharmaceutical industry has been witnessing
remarkable advancements in drug delivery technologies. These innovations aim to
improve the efficacy, precision, and patient compliance of drug formulations.
Organic pharmaceutical excipients are often at the forefront of these
developments. They are utilized in various drug delivery systems, such as
nanoparticles, liposomes, and microspheres, to enhance drug solubility,
stability, and controlled release. These technological advancements are
contributing significantly to the growth of the organic excipients market.
The Global Organic Pharmaceutical Excipients Market is
segmented into Type, Functions, Application, Regional Distribution, And Company.
Based on the Type, Carbohydrates emerged
as the dominant segment in the global market for Global Organic Pharmaceutical
Excipients Market in 2022. Carbohydrates like cellulose and its derivatives can
be employed in a wide range of drug delivery systems. They are used as binders,
fillers, disintegrants, and coating agents in various oral and topical
formulations. Carbohydrates are naturally occurring in our diets, making them
generally recognized as safe (GRAS). This biocompatibility means that they have
minimal toxicity and adverse reactions when used as excipients. Carbohydrates,
being abundant in nature, especially from plant sources, are relatively
cost-effective to produce and process compared to some other excipient types.
Based on the Application, the Oral Formulations
segment emerged as the dominant player in the global market for Global Organic
Pharmaceutical Excipients Market in 2022. Oral medications, such as tablets and
capsules, are among the most preferred dosage forms by patients. They are
convenient, easy to administer, and do not require special skills or equipment,
enhancing patient compliance. Oral formulations cover a wide spectrum of
pharmaceutical products, from over the counter (OTC) drugs and vitamins to
prescription medications. This diversity results in a consistently high demand
for excipients in oral drug development. Oral formulations allow for precise
dosing and the incorporation of various excipients to achieve desired drug
release profiles, such as immediate-release, extended-release, or
sustained-release, depending on the therapeutic goal. Oral formulations can be designed for targeted drug
delivery to specific regions of the gastrointestinal tract, improving drug
absorption and therapeutic outcomes.
Based on the Functions, the Disintegrants segment
emerged as the dominant player in the global market for Global Organic
Pharmaceutical Excipients Market in 2022. Disintegrants play a crucial role in
promoting the rapid breakdown and dissolution of solid dosage forms such as
tablets and capsules. This property is vital for ensuring that the active
pharmaceutical ingredient (API) is released quickly and effectively in the
body, leading to faster onset of action. By facilitating the disintegration and
subsequent dissolution of the drug, disintegrants can significantly improve the
bioavailability of poorly water-soluble APIs. This is essential for enhancing
the therapeutic efficacy of many medications. Tablets that disintegrate rapidly
are easier for patients to swallow and are more likely to be taken as
prescribed. Improved patient compliance is a critical factor in the
effectiveness of pharmaceutical treatments.
North America emerged as the dominant player in the
global Organic Pharmaceutical Excipients Market in 2022, holding the largest
market share. North America boasts one of the world's largest and most advanced
pharmaceutical industries. The presence of numerous pharmaceutical companies,
research institutions, and a well-established healthcare infrastructure has
contributed to a high demand for excipients. Regulatory bodies such as the U.S.
Food and Drug Administration (FDA) and Health Canada have stringent standards
for pharmaceutical formulations. Organic pharmaceutical excipients, known for
their safety and compatibility, align well with these strict regulatory
requirements, making them a preferred choice for drug formulation in North
America. The North
American consumer base has shown a strong preference for clean-label and
natural products in recent years. This trend extends to pharmaceuticals, where
consumers are seeking medications with fewer synthetic additives and more
natural ingredients. Organic excipients align perfectly with this demand for
clean-label pharmaceuticals.
Major companies operating in Global Organic
Pharmaceutical Excipients Market are:
- Roquette Freres SA
- DuPont de Nemours Inc.
- Ashland Inc.
- BASF SE
- Kerry Group plc
- Evonik Industries AG
- Croda International plc
- The Lubrizol Corporation
- Innophos Holdings Inc.
- Wacker Chemie AG
Download
Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global
Organic Pharmaceutical Excipients Market is poised for substantial growth in
the coming years. Anticipated to be driven by factors such as the increasing
consumer demand for clean-label and sustainable pharmaceutical products, the
pharmaceutical industry's focus on eco-friendly practices, and regulatory
support for organic excipients, this market is set to expand significantly.
Additionally, advancements in drug delivery technologies and the rising
prevalence of chronic diseases are expected to boost the adoption of organic
excipients in pharmaceutical formulations. North America's dominance, driven by
a robust pharmaceutical industry and strict regulatory standards, is likely to
continue, while other regions are also expected to witness substantial growth.”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Organic Pharmaceutical Excipients Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By
Type (Oleochemicals, Carbohydrates, Petrochemicals, Protein, Other), By
Functions (Binders, Coating Agents, Colorants; Disintegrates, Other Functions),
By Application (Oral Formulations, Topical Formulations, Parenteral
Formulations, Other Applications) By Region and Competition”, has evaluated
the future growth potential of Global Organic Pharmaceutical Excipients Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Organic Pharmaceutical Excipients
Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com